• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'childhood acute lymphoblastic leukemia all'

A gyermekkori akut limfoid leukémiára való hajlam genetikai, valamint a kezelésre adott válasz farmakogenetikai vizsgálata

(2006) Methylenetetrahydrofolate reductase C677T polymorphism: Association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of

Protected

N/A

152
0
0
2022
The genomic landscape of teenage and young adult T- cell acute lymphoblastic leukemia

A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozy- gosity, and association

Protected

N/A

10
0
0
2022
The role of genetic polymorphism of transporter proteins in acut lymphoblastic leukemia and other diseases; pharmacogenetic studies

The studied polymorphisms of ABCB1 and ABCG2 genes and the haplotypes of these do not influence the development of childhood acute lymphoblastic leukemia on the

Protected

N/A

11
0
0
2022
Abstract SubgroupsofPaediatricAcuteLymphoblasticLeukaemiaMightDifferSignificantlyinGeneticPredispositiontoAsparaginaseHypersensitivity

(2015) Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia... Erdelyi DJ, Kamory E, Csokay

Protected

N/A

12
0
0
2022
Roles of Genetic Polymorphisms in the Folate Pathway in Childhood Acute Lymphoblastic Leukemia Evaluated by Bayesian Relevance and Effect Size Analysis

(2013) Roles of Genetic Polymorphisms in the Folate Pathway in Childhood Acute Lymphoblastic Leukemia Evaluated by Bayesian Relevance and Effect Size Analysis.. This is an

Protected

N/A

13
0
0
2022
Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)

(a.) P- 4EBP1 ODs are shown for normal control peripheral blood mononuclear cells (N1, N2, N3), isolated peripheral normal B- and T-cells (B, T), isolated peripheral blood

Protected

N/A

11
0
0
2022
H HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with ahigh risk of asparaginase hypersensitivity inacute lymphoblastic leukemia

The BN-BMLA approach was used to investigate the different dependency rela- tions between HLA alleles, age, acute lymphoblastic leukemia (ALL) immunophenotype, sex,

Protected

N/A

9
0
0
2022
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia

In order to further examine the value of the 4 selected miRs as MRD biomarkers, we tested their associations with results of other MRD measurement methods and with various

Protected

N/A

16
0
0
2022
Egyetemi laborokban készülnek a láthatatlanná tevő köpenyek megtekintése

A New Jersey állambeli Rutgers Egyetem kutatói januárban egy olyan rugalmas, 3D-nyomtatással készített anyag (hivatalosan okos gél) kifejlesztését jelentették be,

Protected

N/A

1
0
0
2022
Czuber – Burkhardt: Die statistischen Forschungsmethoden

Több szép térképvázlat és fényképfelvé- tel is élénkíti a munkát, amely méltán számíthat a statisztikusok érdeklődésére is, mert —-— mint a kötetet befejező

Protected

N/A

1
0
0
2022
Magyar költő Európában

A magyarság etnikai képének rajzolgatása idején, amikor Szabó Dezső „faji kultúra"-fogalma általánosan használt kategória volt, sőt sokan már a fajelmélet brutális

Protected

N/A

4
0
0
2022
Gondozás és prevenció az autizmussal élő gyermeket nevelő családok körében (doktori értekezés tézisei)

Orsolya Tobak, Mónika Balogh, Kinga Lampek dr: The nursing options of health visitors in families bringing up children with autism in Hungary.. New

Protected

N/A

16
0
0
2022
Determination of mTOR kinase activity and investigation of therapeutic options of rapamycin in childhood acute lymphoblastic leukemia

In bone marrow cells isolated from childhood ALL patients (n = 4) and treated with rapamycin in vitro, the expression of p-4EBP1 significantly decreased in samples

Protected

N/A

15
0
0
2022
Impact of Single Nucleotide Polymorphisms of Cytarabine Metabolic Genes on Drug Toxicity in Childhood Acute Lymphoblastic Leukemia

Several studies investigated the influence of the genetic background of the patients on treatment response, side effects and patient survival [25,26], but only a few studies

Protected

N/A

7
0
0
2022
MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia

Detection of occult cerebrospinal fluid involve- ment during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse. van

Protected

N/A

12
0
0
2022
Informatikusnak készülsz? Itt vannak a legmenőbb egyetemek megtekintése

A világ harmadik legjobb egyetemének számító Harvard University két éve még épphogy lemaradt a dobogóról, az azóta elért teljesítménye alapján viszont már

Protected

N/A

2
0
0
2022
Genetic susceptibility and pharmacogenetic factors in childhood acute lymphoid leukemia

Evaluating the association of survival rates and the effect of the clinical and genetic factors, either the Frequentist and the BN-BMLA showed that risk group, lineage

Protected

N/A

19
0
0
2022
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukaemia

Based on previous studies 46 microRNAs were selected and their extracellular expressions were examined in peripheral blood, bone marrow and cerebrospinal fluid

Protected

N/A

14
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!